These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36971780)

  • 41. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 cotreatment versus insulin-like growth factor-I alone in two brothers with growth hormone insensitivity syndrome: effects on insulin sensitivity, body composition and linear growth.
    Ekström K; Carlsson-Skwirut C; Ritzén EM; Bang P
    Horm Res Paediatr; 2011; 76(5):355-66. PubMed ID: 21968387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GH and GHR signaling in human disease.
    Guevara-Aguirre J; Guevara A; Palacios I; Pérez M; Prócel P; Terán E
    Growth Horm IGF Res; 2018 Feb; 38():34-38. PubMed ID: 29395968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone modulates Trypanosoma cruzi infection in vitro.
    Mora-Criollo P; Basu R; Qian Y; Costales JA; Guevara-Aguirre J; Grijalva MJ; Kopchick JJ
    Growth Horm IGF Res; 2022 Jun; 64():101460. PubMed ID: 35490602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel splice site mutation in the growth hormone receptor gene in Turkish patients with Laron-type dwarfism.
    Arman A; Ozon A; Isguven PS; Coker A; Peker I; Yordam N
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):47-58. PubMed ID: 18404972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
    Shibel R; Sarfstein R; Nagaraj K; Lapkina-Gendler L; Laron Z; Dixit M; Yakar S; Werner H
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes mellitus with Laron syndrome: case report.
    Agladıoglu SY; Cetınkaya S; Savas Erdeve S; Onder A; Kendırcı HN; Bas VN; Aycan Z
    J Pediatr Endocrinol Metab; 2013; 26(9-10):955-8. PubMed ID: 23729552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity.
    Kanety H; Hemi R; Ginsberg S; Pariente C; Yissachar E; Barhod E; Funahashi T; Laron Z
    Eur J Endocrinol; 2009 Dec; 161(6):837-44. PubMed ID: 19755405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes.
    Gunter MJ; Leitzmann MF
    J Nutr Biochem; 2006 Mar; 17(3):145-56. PubMed ID: 16426829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai.
    Sethuraman C; Venkatasamy S
    J Pediatr Endocrinol Metab; 2023 May; 36(5):466-469. PubMed ID: 36957988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.
    Messina MF; Arrigo T; Valenzise M; Ghizzoni L; Caruso-Nicoletti M; Zucchini S; Chiabotto P; Crisafulli G; Zirilli G; De Luca F
    J Endocrinol Invest; 2011 Apr; 34(4):292-5. PubMed ID: 20543555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
    Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
    J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity as a major risk factor for cancer.
    De Pergola G; Silvestris F
    J Obes; 2013; 2013():291546. PubMed ID: 24073332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity and cancer: pathophysiological and biological mechanisms.
    Renehan AG; Roberts DL; Dive C
    Arch Physiol Biochem; 2008 Feb; 114(1):71-83. PubMed ID: 18465361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer.
    Yu H; Long W; Zhang X; Xu K; Guo J; Zhao H; Li H; Qing Y; Pan W; Jia B; Zhao HY; Huang X; Wei HJ
    J Transl Med; 2018 Feb; 16(1):41. PubMed ID: 29482569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.
    Moia S; Tessaris D; Einaudi S; de Sanctis L; Bona G; Bellone S; Prodam F
    Ital J Pediatr; 2017 Oct; 43(1):94. PubMed ID: 29025428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.